Export 2 results:
Author Title Type [ Year] Filters: Keyword is n2 diphenylacetyl n (4 ureidomethylbenzyl)argininamide [Clear All Filters]
Neuropeptide Y Y1 receptor antagonism increases bone mass in mice. BoneBone, 51(1), 8 - 16.
(2012). NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target. Current Drug TargetsCurr. Drug Targets, 10(1), 9 - 19.
(2009).